{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:22:50Z","timestamp":1768011770149,"version":"3.49.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.hfc.2021.07.014","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T14:13:34Z","timestamp":1635171214000},"page":"61-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Giuseppe","family":"Palmiero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Vetrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Monda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Dongiglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Lioncino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Di Fraia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Caiazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Verrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Capodicasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cerciello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiore","family":"Manganelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"D'Arienzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"De Rimini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Ascione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Golino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pio","family":"Caso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Ascione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hfc.2021.07.014_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","article-title":"Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"25","author":"Benson","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2021.07.014_bib2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.014_bib3","first-page":"472","article-title":"A\u00a0modern primer on light chain amyloidosis in 592 patients with mass spectrometry-verified typing","volume":"94","author":"Muchtar","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hfc.2021.07.014_bib4","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.0912263107","article-title":"Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38a MAPK pathway","volume":"107","author":"Shi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hfc.2021.07.014_bib5","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.hfc.2021.07.014_bib6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.07.014_bib7","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s12325-015-0250-0","article-title":"Light chain amyloidosis: patient experience survey from the Amyloidosis Research Consortium","volume":"32","author":"Lousada","year":"2015","journal-title":"Adv Ther"},{"key":"10.1016\/j.hfc.2021.07.014_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"issue":"10038","key":"10.1016\/j.hfc.2021.07.014_bib9","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.hfc.2021.07.014_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/heartjnl-2016-310704","article-title":"Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response","volume":"103","author":"Grogan","year":"2017","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.014_bib11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2018.01.017","article-title":"Spectrum of restrictive and infiltrative cardiomyopathies: part 2 of a 2-part series","volume":"71","author":"Pereira","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2021.07.014_bib12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2021.07.014_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2018","journal-title":"Trends Cardiovasc Med"},{"issue":"24","key":"10.1016\/j.hfc.2021.07.014_bib14","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.014_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcmg.2016.04.008","article-title":"Prognosis of light chain amyloidosis with preserved LVEF: added value of 2D speckle-tracking echocardiography to the current prognostic staging system","volume":"10","author":"Barros-Gomes","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.014_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00392-016-1058-x","article-title":"Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis","volume":"106","author":"Mohty","year":"2017","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.014_bib17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0735-1097(89)90254-4","article-title":"Doppler characterization of left ventricular diastolic function in cardiac amyloidosis","volume":"13","author":"Klein","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.014_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/eurheartj\/ehi040","article-title":"Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques","volume":"26","author":"Modesto","year":"2005","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.014_bib19","first-page":"1128","article-title":"Left atrial structure and function in cardiac amyloidosis","volume":"18","author":"Nochioka","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.07.014_bib20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/01.CIR.0000023530.86718.B0","article-title":"Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis","volume":"106","author":"Koyama","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.014_bib21","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.amjcard.2009.01.361","article-title":"Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis","volume":"103","author":"Austin","year":"2009","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.014_bib22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jcmg.2018.02.016","article-title":"Cardiac structural and functional consequences of amyloid deposition by cardiac magnetic resonance and echocardiography and their prognostic roles","volume":"12","author":"Knight","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.014_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11886-010-0108-7","article-title":"Echocardiographic evaluation of cardiac amyloid","volume":"12","author":"Tsang","year":"2010","journal-title":"Curr Cardiol Rep"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.014_bib24","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.014_bib25","doi-asserted-by":"crossref","first-page":"e006588","DOI":"10.1161\/CIRCIMAGING.117.006588","article-title":"Independent prognostic value of stroke volume index in patients with immunoglobulin light chain amyloidosis","volume":"11","author":"Milani","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"19","key":"10.1016\/j.hfc.2021.07.014_bib26","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.hfc.2021.07.014_bib27","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/ehjci\/jew298","article-title":"Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis","volume":"18","author":"Salinaro","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.014_bib28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1540-8175.2010.01238.x","article-title":"A\u00a0novel two-dimensional echocardiographic finding in cardiac amyloidosis","volume":"27","author":"Belkin","year":"2010","journal-title":"Echocardiography"},{"key":"10.1016\/j.hfc.2021.07.014_bib29","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jcmg.2018.07.007","article-title":"Relative left ventricular apical sparing of longitudinal strain in cardiac amyloidosis: is it just amyloid infiltration?","volume":"12","author":"Rapezzi","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.014_bib30","doi-asserted-by":"crossref","first-page":"e005588","DOI":"10.1161\/CIRCIMAGING.116.005588","article-title":"Echo parameters for differential diagnosis in cardiac amyloidosis: a head-to-head comparison of deformation and nondeformation parameters","volume":"10","author":"Pagourelias","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.07.014_bib31","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jacc.2012.04.043","article-title":"Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers","volume":"60","author":"Buss","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.07.014_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis","volume":"9","author":"Ternacle","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/13506129.2017.1417121","article-title":"Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosis","volume":"25","author":"Uzan","year":"2018","journal-title":"Amyloid"},{"issue":"8","key":"10.1016\/j.hfc.2021.07.014_bib34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ehjci\/jes009","article-title":"Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study","volume":"13","author":"Bellavia","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.014_bib35","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ehjci\/jey225","article-title":"Mechanisms of heart failure in transthyretin vs light chain amyloidosis","volume":"20","author":"Binder","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.014_bib36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/ejechocard\/jer289","article-title":"Right ventricular function in AL amyloidosis: characteristics and prognostic implication","volume":"13","author":"Cappelli","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.014_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/13506129.2016.1194264","article-title":"Prognostic value of the right ventricular systolic function in cardiac amyloidosis","volume":"23","author":"Bodez","year":"2016","journal-title":"Amyloid"},{"issue":"13","key":"10.1016\/j.hfc.2021.07.014_bib38","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidosis: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hfc.2021.07.014_bib39","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"(Light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.hfc.2021.07.014_bib40","doi-asserted-by":"crossref","first-page":"e009974","DOI":"10.1161\/JAHA.118.009974","article-title":"Myocardial oxygen consumption and efficiency in patients with cardiac amyloidosis","volume":"7","author":"Clemmensen","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.014_bib41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.echo.2019.11.018","article-title":"Left ventricular pressure-strain-derived myocardial work at rest and during exercise in patients with cardiac amyloidosis","volume":"33","author":"Clemmensen","year":"2020","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.014_bib42","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ehjci\/jeaa097","article-title":"Prognostic implications of left ventricular myocardial work indices in cardiac amyloidosis","volume":"22","author":"Clemmensen","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.014_bib43","doi-asserted-by":"crossref","first-page":"e001346","DOI":"10.1136\/openhrt-2020-001346","article-title":"Amyloidosis Research Network collaborators. Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?","volume":"7","author":"Roger-Roll\u00e9","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.hfc.2021.07.014_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7861\/clinmedicine.3-3-273","article-title":"Cardiovascular magnetic resonance: twenty-first-century solutions in cardiology","volume":"3","author":"Pennell","year":"2003","journal-title":"Clin Med"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.014_bib45","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.014_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0033-0620(99)70014-9","article-title":"Basic principles of magnetic resonance imaging","volume":"42","author":"van Geuns","year":"1999","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.014_bib47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.07.014_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","article-title":"CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis","volume":"7","author":"White","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.014_bib49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/ijri.IJRI_84_18","article-title":"Myocardial nulling pattern in cardiac amyloidosis on time of inversion scout magnetic resonance imaging sequence - a new observation of temporal variability","volume":"28","author":"Mahalingam","year":"2018","journal-title":"Indian J Radiol Imaging"},{"key":"10.1016\/j.hfc.2021.07.014_bib50","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.07.014_bib51","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.07.014_bib52","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2007.08.028","article-title":"Evaluation and management of the cardiac amyloidosis","volume":"50","author":"Selvanayagam","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.07.014_bib53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1148\/radiol.2015142690","article-title":"Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy","volume":"276","author":"Kanda","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.hfc.2021.07.014_bib54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/RLI.0000000000000252","article-title":"Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function","volume":"51","author":"Murata","year":"2016","journal-title":"Investig Radiol"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.014_bib55","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.014_bib56","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.07.014_bib57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.014_bib58","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"issue":"1 Pt 1","key":"10.1016\/j.hfc.2021.07.014_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","article-title":"Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis","volume":"13","author":"Baggiano","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.014_bib60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib62","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcmg.2017.02.012","article-title":"CMR-verified regression of cardiac AL amyloid after chemotherapy","volume":"11","author":"Martinez-Naharro","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12968-017-0419-6","article-title":"The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis","volume":"20","author":"Lin","year":"2018","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.hfc.2021.07.014_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/RTI.0000000000000077","article-title":"Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping","volume":"29","author":"Ferreira","year":"2014","journal-title":"J\u00a0Thorac Imaging"},{"key":"10.1016\/j.hfc.2021.07.014_bib65","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","article-title":"Myocardial edema and prognosis in amyloidosis","volume":"71","author":"Kotecha","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2\u20133","key":"10.1016\/j.hfc.2021.07.014_bib66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pbiomolbio.2012.07.014","article-title":"Histo-anatomical structure of the living isolated rat heart in two contraction states assessed by diffusion tensor MRI","volume":"110","author":"Hales","year":"2012","journal-title":"Prog Biophys Mol Biol"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.014_bib67","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mrm.24488","article-title":"In\u00a0vivo diffusion tensor MRI of the human heart: reproducibility of breath-hold and navigator-based approaches","volume":"70","author":"Nielles-Vallespin","year":"2013","journal-title":"Magn Reson Med"},{"issue":"7","key":"10.1016\/j.hfc.2021.07.014_bib68","doi-asserted-by":"crossref","first-page":"e0132360","DOI":"10.1371\/journal.pone.0132360","article-title":"Heterogeneity of fractional anisotropy and mean diffusivity measurements by in\u00a0vivo diffusion tensor imaging in normal human hearts","volume":"10","author":"McGill","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.014_bib69","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/CIRCULATIONAHA.105.545863","article-title":"Diffusion tensor magnetic resonance imaging mapping the fibre architecture remodelling in human myocardium after infarction: correlation with viability and wall motion","volume":"114","author":"Wu","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.014_bib70","doi-asserted-by":"crossref","first-page":"e007834","DOI":"10.1161\/JAHA.117.007834","article-title":"Myocardial scar delineation using diffusion tensor magnetic resonance tractography","volume":"7","author":"Mekkaoui","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.014_bib71","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jacc.2016.11.051","article-title":"Assessment of myocardial microstructural dynamics by in\u00a0vivo diffusion tensor cardiac magnetic resonance","volume":"69","author":"Nielles-Vallespin","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12968-019-0563-2","article-title":"Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging","volume":"21","author":"Gotschy","year":"2019","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12968-017-0355-5","article-title":"Myocardial perfusion cardiovascular magnetic resonance: optimized dual sequence and reconstruction for quantification","volume":"19","author":"Kellman","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"7","key":"10.1016\/j.hfc.2021.07.014_bib74","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.amjcard.2005.05.057","article-title":"Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure?","volume":"96","author":"Nordlinger","year":"2005","journal-title":"Am J Cardiol"},{"issue":"Suppl. 1","key":"10.1016\/j.hfc.2021.07.014_bib75","first-page":"A24","article-title":"Routine identification of hypoperfusion in cardiac amyloidosis by myocardial blood flow mapping [abstract 028]","volume":"103","author":"Martinez-Naharro","year":"2017","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib76","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00392-020-01661-6","article-title":"Diagnostic value of the novel CMR parameter \u201cmyocardial transit-time\u201d (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy","volume":"110","author":"Chatzantonis","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"5 Pt 1","key":"10.1016\/j.hfc.2021.07.014_bib77","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1161\/01.CIR.88.5.2206","article-title":"Regional left ventricular mechanics in hypertrophic cardiomyopathy","volume":"88","author":"Betocchi","year":"1993","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.014_bib78","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.014_bib79","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.jcmg.2018.07.016","article-title":"Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: a systematic review of existing literature","volume":"12","author":"Tower-Rader","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.014_bib80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcmg.2009.11.013","article-title":"Prognostic significance of strain Doppler imaging in light-chain amyloidosis","volume":"3","author":"Koyama","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib81","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis","volume":"26","author":"Singh","year":"2019","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2021.07.014_bib82","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","article-title":"11C-Pittsburgh B PET imaging in cardiac amyloidosis","volume":"8","author":"Lee","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.07.014_bib83","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.hfc.2021.07.014_bib84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fcvm.2015.00023","article-title":"A\u00a0routine PET\/CT protocol with streamlined calculations for assessing cardiac amyloidosis using (18)F-florbetapir","volume":"2","author":"Osborne","year":"2015","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hfc.2021.07.014_bib85","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hfc.2021.07.014_bib86","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","article-title":"Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis","volume":"22","author":"Galat","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2021.07.014_bib87","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","article-title":"Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis","volume":"25","author":"Stats","year":"2016","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.hfc.2021.07.014_bib88","first-page":"284","article-title":"Binding of serum amyloid P-component (SAP) by amyloid fibrils","volume":"38","author":"Pepys","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.hfc.2021.07.014_bib89","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99 m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4 PART 1","key":"10.1016\/j.hfc.2021.07.014_bib90","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0002-8703(82)90331-3","article-title":"Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the non-invasive diagnosis of cardiac amyloidosis","volume":"103","author":"Wizenberg","year":"1982","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.014_bib91","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0002-9149(83)80140-4","article-title":"Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis","volume":"51","author":"Falk","year":"1983","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.014_bib92","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00259-010-1642-7","article-title":"Usefulness and limitations of 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy","volume":"38","author":"Rapezzi","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"15","key":"10.1016\/j.hfc.2021.07.014_bib93","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jacc.2007.12.038","article-title":"Usefulness of 99mTc-DPD scintigraphy in cardiac amyloidosis","volume":"51","author":"Rapezzi","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib94","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/13506129.2013.871250","article-title":"Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis","volume":"21","author":"Glaudemans","year":"2014","journal-title":"Amyloid"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.014_bib95","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1373\/clinchem.2004.046870","article-title":"Diagnostic performance of quantitative \u03ba and \u03bb free light chain assays in clinical practice","volume":"51","author":"Katzmann","year":"2005","journal-title":"Clin Chem"},{"issue":"9727","key":"10.1016\/j.hfc.2021.07.014_bib96","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib97","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"issue":"2 Pt 1","key":"10.1016\/j.hfc.2021.07.014_bib98","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jcmg.2017.06.020","article-title":"Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.07.014_bib99","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.07.014_bib100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijcard.2017.10.027","article-title":"Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patients with TTR cardiac amyloidosis: an underestimated phenomenon","volume":"254","author":"Cappelli","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2021.07.014_bib101","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study","volume":"57","author":"Law","year":"2016","journal-title":"J\u00a0Nucl Med"},{"issue":"9","key":"10.1016\/j.hfc.2021.07.014_bib102","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Dominantly Inherited Alzheimer Network. Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2021.07.014_bib103","doi-asserted-by":"crossref","first-page":"e002954","DOI":"10.1161\/CIRCIMAGING.114.002954","article-title":"18F-florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study","volume":"8","author":"Park","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib104","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12350-018-1365-x","article-title":"Cardiac amyloidosis imaging with amyloid positron emission tomography: a systematic review and meta-analysis","volume":"27","author":"Kim","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2021.07.014_bib105","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.014_bib106","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12350-017-1059-9","article-title":"Imaging cardiac innervation in amyloidosis","volume":"26","author":"Slart","year":"2019","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.014_bib107","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","article-title":"Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy","volume":"6","author":"Coutinho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.07.014_bib108","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s00259-018-3963-x","article-title":"Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers","volume":"45","author":"Piekarski","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713621000933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713621000933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:42:32Z","timestamp":1761554552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713621000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1551713621000933"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2021.07.014","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2021.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}